Evidence map›Paper›PMID 25527966›Full record

ArticleImmunologic research2015

Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1).

Marco Yamazaki-Nakashimada, José L Maravillas-Montero, Laura Berrón-Ruiz, Orestes López-Ortega, Noé Ramírez-Alejo, Ernesto Acevedo-Ochoa, Francisco Rivas-Larrauri, Beatriz Llamas-Guillén, Lizbeth Blancas-Galicia, Selma Scheffler-Mendoza and 2 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Immunologic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Lymphoblastoid andFrontiers in bioengineering and biotechnology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Marco Yamazaki-NakashimadaDepartamento de Inmunología Clínica, Instituto Nacional de Pediatría, CP 04530, Mexico City, Mexico.
José L Maravillas-Montero
Laura Berrón-Ruiz
Orestes López-Ortega
Noé Ramírez-Alejo
Ernesto Acevedo-Ochoa
Francisco Rivas-Larrauri
Beatriz Llamas-Guillén
Lizbeth Blancas-Galicia
Selma Scheffler-Mendoza
Alberto Olaya-Vargas
Leopoldo Santos-Argumedo
Instituto Nacional de Pediatria · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two patients with a severe leukocyte adhesion deficiency type 1 (LAD-1) phenotype were analyzed by flow cytometry and functional assays to demonstrate the improper adhesive and phagocytic responses of their leukocytes. A single homozygous defect that involves a missense mutation (c.817G>A) that encodes for a G273R substitution in CD18 was identified in both patients. The adhesion and phagocytosis assays demonstrated the inability of patients' leukocytes to perform these functions. Expression of the LFA-1 (CD11a/CD18) on the co-transfected HEK 293 cells with the mutated form of CD18 was not detected. Finally, both patients have been treated with immunoglobulin as an adjunctive therapy with positive results. We propose that intravenous immunoglobulin treatment is safe and efficacious in LAD-1 patients before hematopoietic stem cell transplantation and helpful in controlling severe infections. Subcutaneous immunoglobulin appeared to help wound healing in refractory ulcers in these patients.

Indexed as

Hematopoietic Stem Cell TransplantationCD18 AntigensCell AdhesionChild, PreschoolConsanguinityDNA Mutational AnalysisFeasibility StudiesHEK293 CellsHumansImmunoglobulins, IntravenousInfantLeukocyte-Adhesion Deficiency SyndromeLeukocytesMaleMutation, MissensePedigreeCD18 AntigensImmunoglobulins, Intravenous

Identifiers

PMID25527966
OpenAlexW2059610029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.